This is a summary of the European public assessment report (EPAR) for Sildenafil Teva. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Sildenafil Teva.
Therapeutic Indication
### Therapeutic indication Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Sildenafil Teva to be effective, sexual stimulation is required.
Therapeutic Area (MeSH)
N/AATC Code
G04BE03
ATC Item
sildenafil
Pharmacotherapeutic Group
Drugs used in erectile dysfunction
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| sildenafil | N/A | 西地那非 |
EMA Name
Sildenafil Teva
Medicine Name
Sildenafil Teva
Aliases
N/ANo risk management plan link.
